Skip to main content Help with accessibility Skip to main navigation

CENOBAMATE tablets (Ontozry®▼) for treating focal onset seizures in adults with epilepsy

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 27 - Jan - 2022
Body System:
Amber initiated
CENOBAMATE tablets (Ontozry®▼) for treating focal onset seizures in adults with epilepsy

The Pan Mersey Area Prescribing Committee recommends the prescribing of CENOBAMATE tablets (Ontozry®▼), following specialist initiation, for treating focal onset seizures in adults with epilepsy in accordance with NICE TA753.